Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trialFei Ma, Binghe Xu, Wěi Li et al.|BMJ|2023Cited by 82
RPN11 deubiquitinase promotes proliferation and migration of breast cancer cellsGuoqing Luo, Changsheng Ye|Molecular Medicine Reports|2017Cited by 41